InvestorsHub Logo
Followers 49
Posts 1993
Boards Moderated 0
Alias Born 08/14/2019

Re: None

Thursday, 10/07/2021 11:01:45 AM

Thursday, October 07, 2021 11:01:45 AM

Post# of 198598
Samsung Biologics (KRX: 207940. K.S.), a leading contract development and
manufacturing organization and Enzolytics (ENZC), a drug development company
committed to commercializing multiple proprietary therapeutics to treat
debilitating infectious diseases
, announced the signing of a strategic CDMO
partnership agreement.

BOOM.......MULTI BILLION DOLLAR MARKETS!

HAVE VISION...........see how huge this is!